VGM Research Note — Coverage Needs Fresh Evidence
VGM reached $10.52 with weak momentum, while stale coverage data makes the August distribution declaration the next important piece of evidence.
CAMS Free Update
RCL Research Note — The October Evidence Test
Royal Caribbean retains a strong operating record, but valuation and market extension make October unit economics the next decisive evidence.
XOVR Research Note — The Proxy Faces Live Transmission
XOVR’s August decline suggests SpaceX volatility is reaching the wrapper, with additional supply events keeping redemption resilience in focus.
AAPL Research Note — The Multiple Carries the Risk
Apple’s cash generation remains formidable, but the October report and leadership transition will test a valuation built on multiple durability.
LLY Research Note — Proof After the Gap
Lilly’s post-earnings evidence preserved the franchise case, but recurring margins and oral-program progress still have to support the valuation.
Market Structure: Breadth Holds While Rates Test Growth — August 6, 2026
Broad participation supports a risk-on regime, while a 4.62% ten-year yield tests technology leadership near its 50-day trend.
GLD Research Note — A Broken Price Scale
GLD’s macro thesis survived the August review, but conflicting price series block fresh conclusions about trend, levels and volatility.
Market Structure: Momentum Broadens as Rates Rise — August 5, 2026
Broad trend and participation support a risk-on regime, while a 4.62% ten-year yield and uneven sector momentum define the next test.
COST Research Note — Renewal Nears Its Ceiling
Costco’s 92.2% renewal rate remains elite, but September results must show how member growth and margins can support the premium multiple.
ACGL Research Note — Premium Growth Faces a Test
Slower premium growth, catastrophe exposure and the rate path set the evidence test for Arch Capital through October.